Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management, as it targets up to 10% revenue ...
The biotechnology firm announced it aims to achieve up to 10% revenue growth in 2026 while working toward cash breakeven by 2028. Moderna plans to expand its seasonal vaccine franchise from three to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback